511 related articles for article (PubMed ID: 17630397)
41. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
42. Neuroendocrinology of menopause.
Dasgupta A; Rehman HU
Minerva Ginecol; 2006 Feb; 58(1):25-33. PubMed ID: 16498368
[TBL] [Abstract][Full Text] [Related]
43. The endocrinology of the menopause.
Burger HG
J Steroid Biochem Mol Biol; 1999; 69(1-6):31-5. PubMed ID: 10418978
[TBL] [Abstract][Full Text] [Related]
44. Symptomatology and hormone profile of menopausal Nigerians.
Akingbade OA; Bolarinwa AF; Subbarao VV
Afr J Med Med Sci; 1990 Jun; 19(2):133-7. PubMed ID: 2115729
[TBL] [Abstract][Full Text] [Related]
45. Hormone changes associated with the menopausal transition.
Su HI; Freeman EW
Minerva Ginecol; 2009 Dec; 61(6):483-9. PubMed ID: 19942836
[TBL] [Abstract][Full Text] [Related]
46. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
47. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample.
Burger HG; Dudley EC; Hopper JL; Shelley JM; Green A; Smith A; Dennerstein L; Morse C
J Clin Endocrinol Metab; 1995 Dec; 80(12):3537-45. PubMed ID: 8530596
[TBL] [Abstract][Full Text] [Related]
48. Role of antimüllerian hormone as a biomarker of the menopausal transition.
Iino K; Tarakida A; Abe K; Taniguchi R; Higuchi T; Takahashi I; Mizunuma H
Menopause; 2013 Feb; 20(2):218-22. PubMed ID: 22968251
[TBL] [Abstract][Full Text] [Related]
49. Tubal ligation does not affect hormonal changes during the early menopausal transition.
Nelson DB; Sammel MD; Freeman EW; Gracia CR; Liu L; Langan E
Contraception; 2005 Feb; 71(2):104-10. PubMed ID: 15707559
[TBL] [Abstract][Full Text] [Related]
50. Unpredictable endocrinology of the menopause transition: clinical, diagnostic and management implications.
Burger HG
Menopause Int; 2011 Dec; 17(4):153-4. PubMed ID: 22120939
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition--an analysis of FSH, oestradiol and inhibin.
Burger HG
Eur J Endocrinol; 1994 Jan; 130(1):38-42. PubMed ID: 8124478
[TBL] [Abstract][Full Text] [Related]
52. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
[TBL] [Abstract][Full Text] [Related]
53. Ovarian aging and bone metabolism in menstruating women aged 35-50 years.
Vural F; Vural B; Yucesoy I; Badur S
Maturitas; 2005 Oct; 52(2):147-53. PubMed ID: 16186077
[TBL] [Abstract][Full Text] [Related]
54. Modeling women's health during the menopausal transition: a longitudinal analysis.
Dennerstein L; Lehert P; Guthrie JR; Burger HG
Menopause; 2007; 14(1):53-62. PubMed ID: 17023873
[TBL] [Abstract][Full Text] [Related]
55. Hot flushes and reproductive hormone levels during the menopausal transition.
Dhanoya T; Sievert LL; Muttukrishna S; Begum K; Sharmeen T; Kasim A; Chowdhury O; Bentley GR
Maturitas; 2016 Jul; 89():43-51. PubMed ID: 27180159
[TBL] [Abstract][Full Text] [Related]
56. Inhibins and adult ovarian function.
Laven JS; Fauser BC
Mol Cell Endocrinol; 2004 Oct; 225(1-2):37-44. PubMed ID: 15451566
[TBL] [Abstract][Full Text] [Related]
57. Sexuality.
Dennerstein L; Lehert P; Burger H; Guthrie J
Am J Med; 2005 Dec; 118 Suppl 12B():59-63. PubMed ID: 16414328
[TBL] [Abstract][Full Text] [Related]
58. Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills.
Arbo E; Vetori DV; Jimenez MF; Freitas FM; Lemos N; Cunha-Filho JS
Hum Reprod; 2007 Dec; 22(12):3192-6. PubMed ID: 17981819
[TBL] [Abstract][Full Text] [Related]
59. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age.
Randolph JF; Sowers M; Bondarenko IV; Harlow SD; Luborsky JL; Little RJ
J Clin Endocrinol Metab; 2004 Apr; 89(4):1555-61. PubMed ID: 15070912
[TBL] [Abstract][Full Text] [Related]
60. Hormones and sexuality during transition to menopause.
Gracia CR; Freeman EW; Sammel MD; Lin H; Mogul M
Obstet Gynecol; 2007 Apr; 109(4):831-40. PubMed ID: 17400843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
